Anti-PD-1/CTLA-4 antibody

Clinical trials for Anti-PD-1/CTLA-4 antibody explained in plain language.

Never miss a new study

Get alerted when new Anti-PD-1/CTLA-4 antibody trials appear

Sign up with your email to follow new studies for Anti-PD-1/CTLA-4 antibody, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Triple threat: immunotherapy plus chemo and radiation takes on head and neck cancer

Disease control Recruiting now

This phase 2 trial tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemoradiotherapy can improve outcomes for people with locally advanced head and neck cancer. The study will enroll 27 participants and track how many remain cancer-free aft…

Matched conditions: ANTI-PD-1/CTLA-4 ANTIBODY

Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

Anti-PD-1/CTLA-4 antibody

Get alerted when new Anti-PD-1/CTLA-4 antibody trials appear

Triple threat: immunotherapy plus chemo and radiation takes on head and neck cancer